IVD (in vitro diagnostic) market worth $29 billion in 2007:
This article was originally published in Clinica
The world in vitro diagnostic market is forecast to rise to $29 billion by 2007, according to a new report by Frost & Sullivan. World In Vitro Diagnostics Technologies Markets (www.healthcare.frost.com) notes that lab automation has made significant progress in recent years, but the fact that the workload of this portion of the IVD system is often ad hoc, it is a difficult section to automate. This inevitably leads to bottlenecks in the production process, say F&S analyst Kelly Westfall. The market is currently worth some $20 billion.
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.